United Health Products Secures New Convertible and Equity Financing
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
United Health Products ( (UEEC) ) has provided an update.
On December 16, 2025, United Health Products, Inc. entered into a securities purchase agreement with Alumni Capital LP under which Alumni provided a $289,821 senior convertible promissory note, yielding $250,000 in net proceeds to the company; the note carries 15% annual interest, matures by December 31, 2026, and is convertible into common stock at $0.06 per share, subject to a 9.99% ownership cap and share-reservation requirements. On the same date, the company also signed an Any Market Purchase Agreement with Alumni giving it the right, but not the obligation, to sell up to $4 million of common stock through 2027 based on a discount to recent VWAP levels and issued a five-year warrant to Alumni to purchase up to 3,484,321 shares at $0.075, arrangements that collectively expand United Health Products’ access to equity and convertible financing while potentially diluting existing shareholders as registration statements for resale and offering of the underlying shares are filed and become effective.
More about United Health Products
United Health Products, Inc. operates in the healthcare sector and is focused on developing and commercializing medical products, with its capital-raising activities centered on issuing convertible debt and equity-linked securities to finance its operations and growth plans.
Average Trading Volume: 141,788
Technical Sentiment Signal: Sell
Current Market Cap: $15.06M
Find detailed analytics on UEEC stock on TipRanks’ Stock Analysis page.
